Sedana Medical AB (SEDANA) - Total Liabilities
Based on the latest financial reports, Sedana Medical AB (SEDANA) has total liabilities worth Skr53.68 Million SEK (≈ $5.78 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sedana Medical AB - Total Liabilities Trend (2015–2025)
This chart illustrates how Sedana Medical AB's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Sedana Medical AB's working capital to evaluate short-term liquidity relative to the company's equity base.
Sedana Medical AB Competitors by Total Liabilities
The table below lists competitors of Sedana Medical AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Apetit Oyj
HE:APETIT
|
Finland | €37.60 Million |
|
BCP Investment Corp.
NASDAQ:BCIC
|
USA | $350.91 Million |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €12.54 Million |
|
OPTIMIZERx Corp
NASDAQ:OPRX
|
USA | $48.06 Million |
|
Hasen-Immobilien AG
STU:ABHA
|
Germany | €83.22 Million |
|
Sao Ta Foods JSC
VN:FMC
|
Vietnam | ₫1.79 Trillion |
|
Banco Santander Río S.A
BA:BRIO
|
Argentina | AR$19.89 Trillion |
|
IMI PLC
LSE:IMI
|
UK | GBX1.37 Billion |
Liability Composition Analysis (2015–2025)
This chart breaks down Sedana Medical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sedana Medical AB stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sedana Medical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sedana Medical AB (2015–2025)
The table below shows the annual total liabilities of Sedana Medical AB from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr53.68 Million ≈ $5.78 Million |
-12.24% |
| 2024-12-31 | Skr61.17 Million ≈ $6.58 Million |
+38.82% |
| 2023-12-31 | Skr44.06 Million ≈ $4.74 Million |
-15.97% |
| 2022-12-31 | Skr52.43 Million ≈ $5.64 Million |
-20.71% |
| 2021-12-31 | Skr66.12 Million ≈ $7.12 Million |
+34.94% |
| 2020-12-31 | Skr49.00 Million ≈ $5.27 Million |
+105.28% |
| 2019-12-31 | Skr23.87 Million ≈ $2.57 Million |
+73.76% |
| 2018-12-31 | Skr13.74 Million ≈ $1.48 Million |
-8.24% |
| 2017-12-31 | Skr14.97 Million ≈ $1.61 Million |
-30.81% |
| 2016-12-31 | Skr21.64 Million ≈ $2.33 Million |
+81.05% |
| 2015-12-31 | Skr11.95 Million ≈ $1.29 Million |
-- |
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more